Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.

Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P, Peto R, Pritchard KI, Bergh J, Dowsett M, Hayes DF; EBCTCG.

N Engl J Med. 2017 Nov 9;377(19):1836-1846. doi: 10.1056/NEJMoa1701830.

2.

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.

EBCTCG (Early Breast Cancer Trialists' Collaborative Group), McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R, Whelan T, Wang Y, Wang Z, Darby S.

Lancet. 2014 Jun 21;383(9935):2127-35. doi: 10.1016/S0140-6736(14)60488-8. Epub 2014 Mar 19. Erratum in: Lancet. 2014 Nov 22;384(9957):1848.

3.

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, Godwin J, Gray R, Pierce L, Whelan T, Wang Y, Peto R.

Lancet. 2011 Nov 12;378(9804):1707-16. doi: 10.1016/S0140-6736(11)61629-2. Epub 2011 Oct 19. Review.

4.

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, McGale P, Pan HC, Taylor C, Wang YC, Dowsett M, Ingle J, Peto R.

Lancet. 2011 Aug 27;378(9793):771-84. doi: 10.1016/S0140-6736(11)60993-8. Epub 2011 Jul 28.

5.

A prospective study of children treated for retinoblastoma: cognitive and visual outcomes in relation to treatment.

Ek U, Seregard S, Jacobson L, Oskar K, Af Trampe E, Kock E.

Acta Ophthalmol Scand. 2002 Jun;80(3):294-9.

6.
7.

Tumour cell proliferation after failed ruthenium plaque radiotherapy for posterior uveal melanoma.

Seregard S, Lundell G, Lax I, af Trampe E, Kock E.

Acta Ophthalmol Scand. 1997 Apr;75(2):148-54.

8.

[A study of children with retinoblastoma. Diagnosis is often delayed].

Seregard S, Ek U, Preisler G, af Trampe E, Jacobson L, Oskar K, Illerståhl I, Kock E.

Lakartidningen. 1996 Mar 20;93(12):1133-5. Swedish.

PMID:
8649078
9.

Prevalence of primary acquired melanosis and nevi of the conjunctiva and uvea in the dysplastic nevus syndrome. A case-control study.

Seregard S, af Trampe E, Månsson-Brahme E, Kock E, Bergenmar M, Ringborg U.

Ophthalmology. 1995 Oct;102(10):1524-9.

PMID:
9097801
10.

Intravitreal chemotherapy for recurrent retinoblastoma in an only eye.

Seregard S, Kock E, af Trampe E.

Br J Ophthalmol. 1995 Feb;79(2):194-5. No abstract available.

11.

Standardized precision radiotherapy in choroidal metastases.

Nylén U, Kock E, Lax I, Lundell G, af Trampe E, Wilking N.

Acta Oncol. 1994;33(1):65-8.

PMID:
7511393
12.

Long-term effects of radiotherapy and bromocriptine treatment in patients with previous surgery for macroprolactinomas.

Moberg E, af Trampe E, Wersäll J, Werner S.

Neurosurgery. 1991 Aug;29(2):200-4; discussion 204-5.

PMID:
1886657
13.

External irradiation of growth hormone producing pituitary adenomas: prolactin as a marker of hypothalamic and pituitary effects.

af Trampe EA, Lundell G, Lax I, Werner S.

Int J Radiat Oncol Biol Phys. 1991 Apr;20(4):655-60.

PMID:
2004940
14.

[Radiotherapy of malignant melanoma of the choroid with ruthenium-106 applicator gives good results].

Seregard S, Kock E, Lax I, Lundell G, af Trampe E.

Lakartidningen. 1987 Jul 8;84(28-29):2339-40. Swedish. No abstract available.

PMID:
3613771
15.

[Malignant melanoma of the uvea--a review].

Seregard S, Axelsson U, Kock E, Lundell G, Naeser P, af Trampe E.

Lakartidningen. 1987 Jul 8;84(28-29):2337-8. Review. Swedish. No abstract available.

PMID:
3302566
16.

Retinoblastoma treated with a 60Co applicator.

Kock E, Rosengren B, Tengroth B, af Trampe E.

Radiother Oncol. 1986 Sep;7(1):19-25. No abstract available.

PMID:
3775076
17.

Growth hormone producing pituitary adenomas with concomitant hypersecretion of prolactin are particularly sensitive to photon irradiation.

Werner S, af Trampe E, Palacios P, Lax I, Hall K.

Int J Radiat Oncol Biol Phys. 1985 Sep;11(9):1713-20.

PMID:
4030438
18.

[The retinoblastoma team at Karolinska hospital].

af Trampe E, Backlund EO, Bergström M, Greitz T, Kock E, Lax I, Lindsten J, Lundell G, Tengroth B, Walstam R, Ahström L.

Lakartidningen. 1979 Feb 21;76(8):603-6. Swedish. No abstract available.

PMID:
763033

Supplemental Content

Loading ...
Support Center